Cipcic-Bragadin Mesic & Associates has advised Pfizer on a global business combination with Mylan N.V. The transaction involved a spin-off of Pfizer’s Upjohn business and a subsequent merger of that business with Mylan N.V. to form a new global generics company, called "Viatris." Bird & Bird was global lead counsel to Pfizer, with Karanovic & Partners providing local support for Serbia and Jadek & Pensa providing local support in Slovenia.
Love them or hate them, conferences are a fundamental part of the successful commercial lawyer’s calendar. But time is precious. Those calendars are full. It’s vital for conference organizers to get them right, and critical for lawyers to choose wisely in determining which events to attend and which to skip.
Croatia's Cipcic‑Bragadin law firm has merged with the independent legal practices of Marina Mesic and Ivan Juricic. Following what it calls "the trilateral merger," Marina Mesic becomes a new named partner and Ivan Juricic joins as a senior partner at the firm, which will operate going forward as Cipcic‑Bragadin Mesic and Associates.